drugset / Trial / NCT01415505

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

NCT01415505

Phase 3 Completed 812 enrolled Forest Laboratories
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.

Timeline

Start
2011-08
Primary completion
2013-01
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Nebivolol Other / unclassified 20 mg Oral
Subject Valsartan Small molecule 320 mg Oral
Background Hydrochlorothiazide Unknown 12.5 mg Oral
Background Hydrochlorothiazide Unknown 25 mg Oral